Page 16 - Stephen Hytha News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Life Sciences Company to Acquire Psychedelic Pharmaceutical Firm's Psilocybin Program News Update Streetwise Reports  (12/22/20) Revive Therapeutics reported it has submitted a non-binding letter of intent to acquire 100% of PharmaTher Inc.'s psilocybin program. In a news release, specialty life sciences companyRevive Therapeutics Ltd. (RVV:TSX.V; RVVTF:OTCMKTS), which focuses on developing therapeutics for infectious diseases and rare disorders, announced that it has executed a non-binding letter of intent (LOI) to acquire the full intellectual property (IP) rights pertaining to th...

Humanigen Shares Rise on Completing Phase 1 Brain Cancer Trial Enrollment Source: Streetwise Reports  (12/17/20) Shares of Humanigen Inc. traded 24% higher after the company reported that it had successfully completed enrollment of patients in a Phase 1 Study of ifabotuzumab in glioblastoma multiforme. Clinical stage biopharmaceutical company Humanigen Inc. (HGEN:NASDAQ), which is focused on developing therapies for treating cancer and infectious diseases, today announced that "it is completing enrollment in its Phase 1 bioimaging study of ifabotuzumab in patients with ...

News Update Streetwise Reports  (12/14/20) Avrupa Minerals Ltd. has begun drilling an initial core hole at its Alvalade copper-zinc project located in Portugal's Iberian Pyrite Belt. In a news release, junior exploration and development company Avrupa Minerals Ltd. (AVU:TSX.V; AVPMF:OTC; 8AM:FSE) announced that it has started drilling on the Alvalade Copper-Zinc VMS project located within the Iberian Pyrite Belt in Portugal. Avrupa Minerals stated that its operational plans call for drilling 7,000 to 8,000 meters in the next several months. The firm noted that the drill program was ...

Source: Streetwise Reports  (12/15/20) Shares of Prevail Therapeutics reached a new 52-week high after the company reported it has signed a definitive agreement to be acquired by Ely Lilly in a deal valued up to $1.04 billion. Neurodegenerative disease gene therapy company Prevail Therapeutics Inc. (PRVL:NASDAQ) and global healthcare company Eli Lilly and Co. (LLY:NYSE) today announced that they have entered into a definitive agreement whereby Eli Lilly will acquire Prevail Therapeutics for $22.50 per share in cash for a total purchase price of approximately $880 millio...

URL TICKERS: TLG; CHXMF Explorer Registers Outcrop Samples as High as 80 g/t Gold and 1,060 g/t Silver at Quebec Property News Update Streetwise Reports  (12/13/20) Troilus Gold also reported that it expanded the Beyan Zone 600 meters after recording a 12 g/t Au outcrop sample. Beyan area In a news release, Troilus Gold Corp. (TLG:TSX; CHXMF:OTCQB) announced "the remaining results from its 2020 regional exploration program on its 100%-owned, 107,300 hectare Troilus Gold property, located within the Frôtet-Evans Greenstone Belt in north central Quebec." The firm noted that the resul...